Company news

Sutro Biopharma, Inc. news in 2025

Sutro Biopharma, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

December 17, 2025

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 16, 2025

Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors

December 3, 2025

Sutro Biopharma Announces 1-for-10 Reverse Stock Split

December 1, 2025

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day

November 12, 2025

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights

November 6, 2025

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025

November 5, 2025

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

November 3, 2025

Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones

September 29, 2025

Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights

August 7, 2025

Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates

July 22, 2025

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer

June 2, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025

Sutro Biopharma to Participate in Upcoming Investor Conferences

May 1, 2025

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

April 28, 2025

Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

March 15, 2025

Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights

March 13, 2025

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline

March 13, 2025

Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

March 3, 2025

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale

January 6, 2025

Decks in 2025